Bobbi J. Woolwine

7.7k citations

52 papers · 6.1k indexed · 2 hit papers · h-index 33

Biological Psychiatry top 0.01%
Behavioral Neuroscience top 0.05%
Psychiatry and Mental health top 1%
Neurology top 0.5%
Experimental and Cognitive Psychology top 1%

Co-authors: Andrew H. Miller Ebrahim Haroon Charles L. Raison Jennifer C. Felger Daniel Drake Shuo Chen Pamela J. Schettler Robin E. Rutherford
Topics: Tryptophan and brain disorders (39 papers)Stress Responses and Cortisol (31 papers)Neuroinflammation and Neurodegeneration Mechanisms (10 papers)
Cited by: Biological Psychiatry Behavioral Neuroscience Neurology
Journals: Biological Psychiatry Psychological Medicine Neuropsychopharmacology
Partner nations: United States China Japan

In The Last Decade

Bobbi J. Woolwine

49 papers receiving 6.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A Randomized Controlled Trial of the Tumor Necrosis Factor Antagonist Infliximab for Treatment-Resistant Depression

2012 1.2k citations Charles L. Raison, Bobbi J. Woolwine et al. profile →
CSF concentrations of brain tryptophan and kynurenines during immune stimulation with IFN-α: relationship to CNS immune responses and depression

2009 514 citations C L Raison, Bobbi J. Woolwine et al. Molecular Psychiatry profile →

Peers

Countries citing papers authored by Bobbi J. Woolwine

Since Specialization

Citations

This map shows the geographic impact of Bobbi J. Woolwine's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bobbi J. Woolwine with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bobbi J. Woolwine more than expected).

Fields of papers citing papers by Bobbi J. Woolwine

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bobbi J. Woolwine. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bobbi J. Woolwine. The network helps show where Bobbi J. Woolwine may publish in the future.

Co-authorship network of co-authors of Bobbi J. Woolwine

This figure shows the co-authorship network connecting the top 25 collaborators of Bobbi J. Woolwine. A scholar is included among the top collaborators of Bobbi J. Woolwine based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bobbi J. Woolwine. Bobbi J. Woolwine is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A randomized proof-of-mechanism trial of TNF antagonism for motivational deficits and related corticostriatal circuitry in depressed patients with high inflammation 2024 ·Molecular Psychiatry ·Michael T. Treadway,(unknown),Jessica A. Cooper,(unknown),(unknown),(unknown),(unknown),Amanda R. Arulpragasam,(unknown),(unknown),(unknown),Evanthia C. Wommack,Bobbi J. Woolwine,Mandakh Bekhbat,Philip A. Kragel,Jennifer C. Felger,Ebrahim Haroon,Andrew H. Miller	11
2	Functional connectivity in reward circuitry and symptoms of anhedonia as therapeutic targets in depression with high inflammation: evidence from a dopamine challenge study 2022 ·Molecular Psychiatry ·Mandakh Bekhbat,Zhihao Li,(unknown),Michael T. Treadway,Michael J. Lucido,Bobbi J. Woolwine,Ebrahim Haroon,Andrew H. Miller,Jennifer C. Felger	60
3	Transcriptomic signatures of psychomotor slowing in peripheral blood of depressed patients: evidence for immunometabolic reprogramming 2021 ·Molecular Psychiatry ·Mandakh Bekhbat,David R. Goldsmith,Bobbi J. Woolwine,Ebrahim Haroon,Andrew H. Miller,Jennifer C. Felger	20
4	Antidepressant treatment resistance is associated with increased inflammatory markers in patients with major depressive disorder 2018 ·Psychoneuroendocrinology ·Ebrahim Haroon,(unknown),Bobbi J. Woolwine,David R. Goldsmith,Wendy Baer,Evanthia C. Wommack,Jennifer C. Felger,Andrew H. Miller	215
5	Increased inflammation and brain glutamate define a subtype of depression with decreased regional homogeneity, impaired network integrity, and anhedonia 2018 ·Translational Psychiatry ·Ebrahim Haroon,Xiangchuan Chen,Zhihao Li,(unknown),Bobbi J. Woolwine,Xiaoping Hu,Jennifer C. Felger,Andrew H. Miller	80
6	Glucose and lipid-related biomarkers and the antidepressant response to infliximab in patients with treatment-resistant depression 2018 ·Psychoneuroendocrinology ·Mandakh Bekhbat,Karen Chu,Ngoc‐Anh Le,Bobbi J. Woolwine,Ebrahim Haroon,Andrew H. Miller,Jennifer C. Felger	49
7	Inflammation negatively correlates with amygdala-ventromedial prefrontal functional connectivity in association with anxiety in patients with depression: Preliminary results 2018 ·Brain Behavior and Immunity ·Neeti D. Mehta,Ebrahim Haroon,Xiaodan Xu,Bobbi J. Woolwine,Zhihao Li,Jennifer C. Felger	80
8	Inflammatory markers are associated with decreased psychomotor speed in patients with major depressive disorder 2016 ·Brain Behavior and Immunity ·David R. Goldsmith,Ebrahim Haroon,Bobbi J. Woolwine,(unknown),Evanthia C. Wommack,Philip D. Harvey,Michael T. Treadway,Jennifer C. Felger,Andrew H. Miller	102
9	Inhibition of tumor necrosis factor improves sleep continuity in patients with treatment resistant depression and high inflammation 2014 ·Brain Behavior and Immunity ·Jeremy Weinberger,Charles L. Raison,David B. Rye,(unknown),Bobbi J. Woolwine,Jennifer C. Felger,Ebrahim Haroon,Andrew H. Miller	69
10	IFN-Alpha-Induced Cortical and Subcortical Glutamate Changes Assessed by Magnetic Resonance Spectroscopy 2014 ·Neuropsychopharmacology ·Ebrahim Haroon,Bobbi J. Woolwine,Xiangchuan Chen,Thaddeus W. W. Pace,Samir Parekh,James R. Spivey,Xiaoping Hu,Andrew H. Miller	133
11	Tyrosine metabolism during interferon-alpha administration: Association with fatigue and CSF dopamine concentrations 2012 ·Brain Behavior and Immunity ·Jennifer C. Felger,Li Li,Paul J. Marvar,Bobbi J. Woolwine,David G. Harrison,Charles L. Raison,Andrew H. Miller	146
12	Early activation of p38 mitogen activated protein kinase is associated with interferon-alpha-induced depression and fatigue 2011 ·Brain Behavior and Immunity ·Jennifer C. Felger,Oyetunde Alagbe,Thaddeus W. W. Pace,Bobbi J. Woolwine,Fang Hu,Charles L. Raison,Andrew H. Miller	34
13	Activation of Central Nervous System Inflammatory Pathways by Interferon-Alpha: Relationship to Monoamines and Depression 2008 ·Biological Psychiatry ·Charles L. Raison,Andrey Borisov,Matthias Majer,Daniel Drake,Giuseppe Pagnoni,Bobbi J. Woolwine,Gerald Vogt,(unknown),Andrew H. Miller	306
14	Interferon-α effects on diurnal hypothalamic–pituitary–adrenal axis activity: relationship with proinflammatory cytokines and behavior 2008 ·Molecular Psychiatry ·C L Raison,Andrey Borisov,Bobbi J. Woolwine,(unknown),Gerald Vogt,Andrew H. Miller	156
15	Basal Ganglia Hypermetabolism and Symptoms of Fatigue during Interferon-α Therapy 2007 ·Neuropsychopharmacology ·Lucile Capuron,Giuseppe Pagnoni,(unknown),David H. Lawson,(unknown),Bobbi J. Woolwine,Gregory S. Berns,Charles B. Nemeroff,Andrew H. Miller	198
16	Paroxetine for prevention of depressive symptoms induced by interferon‐alpha and ribavirin for hepatitis C 2007 ·Alimentary Pharmacology & Therapeutics ·Charles L. Raison,Bobbi J. Woolwine,(unknown),Andrey Borisov,(unknown),Jeffrey P. Staab,John Zajecka,(unknown),Max Henderson,John F. Reinus,Dwight L. Evans,Gregory M. Asnis,Andrew H. Miller	114
17	Promoter Polymorphisms of the Interferon-α Receptor Gene and Development of Interferon-Induced Depressive Symptoms in Patients with Chronic Hepatitis C: Preliminary Findings 2005 ·Neuropsychobiology ·Keizo Yoshida,Oyetunde Alagbe,Xiaohong Wang,Bobbi J. Woolwine,(unknown),Charles L. Raison,Andrew H. Miller	31
18	Depressive symptoms and viral clearance in patients receiving interferon-α and ribavirin for hepatitis C 2004 ·Brain Behavior and Immunity ·Charles L. Raison,Sherry D. Broadwell,Andrey Borisov,Amita K. Manatunga,Lucile Capuron,Bobbi J. Woolwine,Ira M. Jacobson,Charles B. Nemeroff,Andrew H. Miller	115
19	Increased Early Life Stress and Depressive Symptoms in Patients With Comorbid Substance Abuse and Schizophrenia 2002 ·Schizophrenia Bulletin ·(unknown),Samantha M. Thomas,Bobbi J. Woolwine,Andrew H. Miller	37
20	Double Jeopardy: Schizophrenia and Substance Use 2000 ·The American Journal of Drug and Alcohol Abuse ·(unknown),(unknown),Andrew H. Miller,Bobbi J. Woolwine,(unknown)	72

About Bobbi J. Woolwine

Bobbi J. Woolwine is a scholar working on Biological Psychiatry, Behavioral Neuroscience and Neurology, having authored 52 papers that have together received 6.1k indexed citations. Recurring topics across this work include Tryptophan and brain disorders (39 papers), Stress Responses and Cortisol (31 papers) and Neuroinflammation and Neurodegeneration Mechanisms (10 papers). The work is most often cited by research in Biological Psychiatry (4.4k citations), Behavioral Neuroscience (3.2k citations) and Neurology (1.1k citations). Bobbi J. Woolwine has collaborated with scholars based in United States, China and Japan. Frequent co-authors include Andrew H. Miller, Ebrahim Haroon, Charles L. Raison, Jennifer C. Felger, Daniel Drake, Shuo Chen, Pamela J. Schettler, Robin E. Rutherford, Gerald Vogt and James R. Spivey. Their work appears in journals such as Biological Psychiatry, Psychological Medicine and Neuropsychopharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact